Cytotoxcity of some potential DNA intercalators (Carbazole, acridine and anthracene derivatives) evaluated through neutrophil chemiluminescence

Journal of Applied Toxicology

Volumn 20, Issue 4, 2000, Pages 305-312

  Sajewicz, Waldemar ^a   Dlugosz, Anna ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Cytotoxicity; Neutrophil chemiluminescence; Potential DNA intercalators

Indexed keywords

ACRIDINE DERIVATIVE; ANTHRACENE DERIVATIVE; CARBAZOLE DERIVATIVE; DOXORUBICIN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; INTERCALATING AGENT; MYELOPEROXIDASE; REACTIVE OXYGEN METABOLITE; XANTHINE OXIDASE; ACETALDEHYDE; CARBAZOLE; PEROXIDASE;

ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; NEUTROPHIL; PHAGOCYTOSIS; PRIORITY JOURNAL; ADULT; CELL DIVISION; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; IN VITRO STUDY; METABOLISM; PHYSIOLOGY;

ACETALDEHYDE; ACRIDINES; ADULT; ANTHRACENES; CARBAZOLES; CELL DIVISION; CHEMILUMINESCENT MEASUREMENTS; HUMANS; INTERCALATING AGENTS; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; PEROXIDASE; PHAGOCYTOSIS; XANTHINE OXIDASE;

EID: 0033624154     PISSN: 0260437X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-1263(200007/08)20:4<305::aid-jat659>3.0.co;2-p     Document Type: Article

References (37)

1. Allen RC. Phagocytic leukocyte oxygenation activities and chemiluminescence: a kinetic approach to analysis. In Methods in Enzymology, vol. 133, De Luca MA, Mc Elroy WD (eds). Academic Press: New York, 1986; 449-493.
2. Trush MA. Chemiluminescence as a probe to investigate chemical-cell interactions: a toxicological perspective. In Cellular Chemiluminescence, vol. III, Van Dyke K, Castranova V (eds). CRC Press: Bocca Raton, FL, 1987; 185-205.
3. Sajewicz W. Polymorphonuclear leukocyte chemiluminescence as a method for investigating the cytotoxicity of chemical compounds. PHD Thesis, Wroclaw University of Medicine, 1994.
4. Thelen M, Dewald B, Baggiolini M. Neutrophil signal transduction and activation of the respiratory burst. Physiol. Rev. 1993; 73: 797-821.
5. Klebanoff SJ. Oxygen metabolism and the toxic properties of phagocytes. Ann. Intern. Med. 1980; 93: 480-489.
6. Albrecht D, Jungi TW. Luminol-enhanced chemiluminescence induced in peripheral blood-derived phagocytes: obligatory requirement of myeloperoxidase exocytosis by monocytes. J. Leukocyte Biol. 1993; 54: 300-306.
7. Stevens P. Lucigenin and luminol-dependent chemiluminescence to selectively differentiate the oxidative pathways of phagocytic cells. In Cellular chemiluminescence, vol. I, Van Dyke K, Castranova V (eds). CRC Press: Bocca Raton, FL, 1987; 105-112.
8. Vondraček J, Lojek A, Čiž M, Dušková M. Effects of some lipoxygenase and cyclooxygenase inhibitors on the luminol-enhanced chemiluminescence of phagocytes. Int. J. Immunopathol. Pharmacol. 1996; 9: 101-107.
9. Van Dyke K, Castranova V (eds). Cellular Chemiluminescence, Vois 1-3. CRC Press: Bocca Raton, FL, 1987.
10. Takahashi R, Edashide K, Sato EF, Inoue M, Matsuno T, Utsumi K. Luminol chemiluminescence and active oxygen generation by activated neutrophils. Arch. Biochem. Biophys. 1991; 285: 325-330.
11. Follin P, Johansson A, Dahlgren C. Intracellular production of reactive oxygen species in human neutrophils following activation by the soluble stimuli FMLP, dioctanoylglycerol and ionomycin. Cell Biochem. Funct. 1991; 9: 29-37.
12. Dahlgren C. Effect of different inhibitors on the intracellularly and extracellularly generated chemiluminescence induced by formylmethionyl-leucyl-phenylalanine in polymorphonuclear leukocytes. Cellular response in the presence of mannitol, benzoate, taurine, indomethacin and NDGA. J. Biolumin. Chemilumin. 1991; 6: 29-34.
13. Pierce LA, Tarnow-Mordi WO, Cree IA. Antibiotic effects on phagocyte chemiluminescence in vitro. Int. J. Clin. Lab. Res. 1995; 25: 93-98.
14. Marzzullo L, Souza LC, Campa A. Effect of amphotericin B associated with a lipid emulsion on the oxidative burst of human polymorphonuclear leukocytes. Gen. Pharmacol. 1997; 28: 203-207.
15. Sha S, Schacht J. Stimulation of free radical formation by aminoglycoside antibiotics. Hear. Res. 1999; 128: 112-118.
16. Ueta E, Osaki T. Suppression by anticancer agents of reactive oxygen generation from polymorphonuclear leukocytes. Free Radical Res. 1996; 24: 39-53.
17. Czuba ZP, Krol W, Hasinski P, Nowowiejska A. The effects of taxol (paclitaxel) on chemiluminescence of neutrophils, macrophages and J. 774.2 cell line. Acta Biochim. Pol. 1998; 45: 103-106.
18. Kolachana P, Subrahmanyam VV, Meyer KB, Zhang L, Smith MT. Benzene and its phenolic metabolites produce oxidative DNA damage in HL60 cells in vitro and in the bone marrow in vivo. Cancer Res. 1993; 53: 1023-1026.
19. Shen HM, Ong CN, Lee BL, Shi CY. Aflatoxin B1-induced 8-hydroxy-deoxyguanosine formation in rat hepatic DNA. Carcinogenesis 1995; 16: 419-422.
20. Mauthe, RJ, Cook VM, Coffing SL, Baird WM. Exposure of mammalian cell cultures to benzo[a]pyrene and light results in oxidative DNA damage as measured by 8-hydroxydeoxyguanosine formation. Carcinogenesis 1995; 16: 133-137.
21. Baugley BC. DNA intercalating antitumor agents. Anticancer Drug Design 1991; 6: 1-35.
22. Doroshow J. Effects of anthracycline antibiotics on oxygen radical formation in the heart. Cancer Res. 1983; 43: 460-472.
23. Rajagopalan S, Politi P, Sinha PM, Mayers CE. Adriamycin-induced free radical formation in the perfused rat heart: implications for cardiotoxicity. Cancer Res. 1988; 48: 4766-4769.
24. Boyd MR. Status of the NCI preclinical antitumor drug discovery screen. Princ. Pract. Oncol. 1989; 3: 1-12.
25. Jones DA, Fitzpatrick FA. Genomics and the discovery of new drug targets. Curr. Opin. Chem. Biol. 1999; 3: 71-76.
26. Buolamwini JK. Novel anticancer drug discovery Curr. Opin. Chem. Biol. 1999; 3: 500-509.
27. Dlugosz A. Synthesis and cytotoxicity of the three-membered aromatic pyrimidine derivatives, Acta Pol. Pharm. 1997; 54: 357-362.
28. Böyum A. Isolation of lymphocytes, granulocytes and macrophages. Scand. J. Immunol. 1976; 5: (Supll. 5), 9-15.
29. Westman JA. Influence of pH and temperature on the luminol-dependent chemiluminescence of human polymorphonuclear leukocytes. Scand. J. Clin. Invest. 1986; 46: 427-434.
30. McNally JA, Bell AL. Myeloperoxidase-based chemiluminescence of polymorphonuclear leukocytes and monocytes. J. Biolumin. Chemilumin. 1996; 11: 99-106.
31. Hodgson EK, Fridovich I. The mechanism of the activity-dependent luminescence of xanthine oxidase. Arch. Biochem. Biophys. 1976; 172: 202-205.
32. Matsui H, Wada O, Ushijima Y, Mizuta T. Inhibition of oxidative metabolism in rabbit polymorphonuclear leukocytes by triphenyltin chloride. Arch. Toxicol. 1983; 54: 227-233.
33. Mason RP, Rao DNR. Thiyl free radical metabolites of thiol drugs, glutathione, and proteins. In Methods in Enzymology, vol. 186, Packer L, Glazer AN (eds). Academic Press: San Diego, 1990; 318-329.
34. Asmus KD. Sulfur-centered free radicals. In Methods in Enzymology, vol. 186, Packer L, Glazer AN (eds). Academic Press: San Diego, 1990; 168-180.
35. Akman SA, Dorshow JH, Burke TG, Dizdaroglu M. DNA base modifications induced in isolated human chromatin by NADH dehydrogenase-catalyzed reduction of doxorubicin. Biochemistry 1992; 31: 3500-3506.
36. Minotti G. NADPH- and adriamycin-dependent microsomal release of iron and lipid peroxidation. Arch. Biochem. Biphys. 1990; 277: 268-276.
37. Reszka KJ, Chignell CF. Acid-catalyzed oxidation of the anticancer agent mitoxantrone by nitrite ions. Molecul. Pharmacol. 1996; 50: 1612-1618.